Cargando…
Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673873/ https://www.ncbi.nlm.nih.gov/pubmed/34921753 http://dx.doi.org/10.1016/S2213-8587(21)00326-0 |
| _version_ | 1784615534655963136 |
|---|---|
| author | Kosiborod, Mikhail N Esterline, Russell Oscarsson, Jan Gasparyan, Samvel B Furtado, Remo H M Verma, Subodh Berwanger, Otavio |
| author_facet | Kosiborod, Mikhail N Esterline, Russell Oscarsson, Jan Gasparyan, Samvel B Furtado, Remo H M Verma, Subodh Berwanger, Otavio |
| author_sort | Kosiborod, Mikhail N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8673873 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86738732021-12-16 Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply Kosiborod, Mikhail N Esterline, Russell Oscarsson, Jan Gasparyan, Samvel B Furtado, Remo H M Verma, Subodh Berwanger, Otavio Lancet Diabetes Endocrinol Correspondence Elsevier Ltd. 2022-02 2021-12-15 /pmc/articles/PMC8673873/ /pubmed/34921753 http://dx.doi.org/10.1016/S2213-8587(21)00326-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Kosiborod, Mikhail N Esterline, Russell Oscarsson, Jan Gasparyan, Samvel B Furtado, Remo H M Verma, Subodh Berwanger, Otavio Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply |
| title | Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply |
| title_full | Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply |
| title_fullStr | Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply |
| title_full_unstemmed | Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply |
| title_short | Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply |
| title_sort | dapagliflozin in patients with covid-19: mind the kidneys – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673873/ https://www.ncbi.nlm.nih.gov/pubmed/34921753 http://dx.doi.org/10.1016/S2213-8587(21)00326-0 |
| work_keys_str_mv | AT kosiborodmikhailn dapagliflozininpatientswithcovid19mindthekidneysauthorsreply AT esterlinerussell dapagliflozininpatientswithcovid19mindthekidneysauthorsreply AT oscarssonjan dapagliflozininpatientswithcovid19mindthekidneysauthorsreply AT gasparyansamvelb dapagliflozininpatientswithcovid19mindthekidneysauthorsreply AT furtadoremohm dapagliflozininpatientswithcovid19mindthekidneysauthorsreply AT vermasubodh dapagliflozininpatientswithcovid19mindthekidneysauthorsreply AT berwangerotavio dapagliflozininpatientswithcovid19mindthekidneysauthorsreply |